Skip to content
Screener

G&A at other companies

Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$110.21M+172%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$19.38M+43.5%
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
$8.49M+54.9%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
$8.75M+106%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$5.71M-5.2%
Eikon Therapeutics, Inc. logo
Eikon Therapeutics, Inc.EIKN
$17.29M+16.9%

Other financials

Income statement

See full
Operating income-$187.9M-427%
Net income-$183.4M-492%
EPS (diluted)-$0.60-445%

Balance sheet

See full
Cash & equivalents$47.3M-33.0%
Total debt$46.0M-9.6%
Total equity$393.5M-1.5%
Total assets$461.2M-2.1%

Cash flow

See full
Operating cash flow-$27.4M+13.2%
CapEx$36.0K-56.6%
Free cash flow-$27.4M+13.3%

Valuation

See full
Market cap$6.34B+1,466%
Enterprise value$6.34B+1,533%

Returns & leverage

See full
Return on equity-69.9%+77.1pp
Debt / equity0.1×0.0×
Current ratio9.5×-2.8×

Where this comes from

Reported directly by Erasca, Inc. in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Erasca, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216788
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Operating expenses:
Research and development$27,265$25,969
In-process research and development150,000
General and administrative10,6469,661
Total operating expenses187,91135,630
Loss from operations(187,911)(35,630)
Other income (expense)
Interest income4,4494,740

Item 1. Financial Statements.

FAQ

What is Erasca, Inc.'s G&A?
Erasca, Inc. (ERAS) reported G&A of $10.65M in Q1 2026.
How has Erasca, Inc.'s G&A changed year-over-year?
Erasca, Inc.'s G&A increased by 10.2% year-over-year, from $9.66M to $10.65M.
What is the long-term trend for Erasca, Inc.'s G&A?
Over 4 years (2021 to 2025), Erasca, Inc.'s G&A has grown at a 14.3% compound annual growth rate (CAGR), from $22.62M to $38.55M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Ask your AI about Erasca, Inc.'s g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude